Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Protocol for Newky Diagnosed Adult Ph-Chromosome Positive (BCR::ABL1) Acute Lymphoblastic Leukemia (LALPh2022)

NCT06175702 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT06175702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06175702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Protocol for Newky Diagnosed Adult Ph-Chromosome Positive (BCR::ABL1) Acute Lymphoblastic Leukemia (LALPh2022)
Lead sponsor
PETHEMA Foundation
Phase
Observational
Overall status
Not yet recruiting
Start date
December 25, 2023
Completion date
December 25, 2030
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adult all, lymphoblastic leukemia, philadelphia-positive all